Erythropoietin in HIE Neonate
NCT06590155 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2024-09-19
Summary
this study is aim to delineate the role of erythropoietin in improving neonatal hypoxic ischemic encephalopathy the study is conducted to answer the question : is erythropoietin will improve neonatal hypoxic ischemic encephalopathy?
Conditions
- Neonatal Hypoxic Ischemic Encephalopathy
Interventions
- DRUG
-
Erythropoietin
the role of erythropoietin in improving neonatal hypoxic ischemic encephalopathy
Sponsors & Collaborators
-
Assiut University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Day
- Max Age
- 1 Month
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-24
- Primary Completion
- 2029-02-24
- Completion
- 2029-02-24
Countries
- Egypt
Study Locations
More Related Trials
-
High-dose Erythropoietin for Asphyxia and Encephalopathy
NCT02811263 ·Status: COMPLETED ·Phase: PHASE3
-
High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study
NCT00589953 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome
NCT03110341 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrhage
NCT03914690 ·Status: COMPLETED ·Phase: PHASE2
-
Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy
NCT00808704 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neuroprotective Role of Erythropoietin in Perinatal Asphyxia
NCT02002039 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Neonatal Erythropoietin in Asphyxiated Term Newborns
NCT00719407 ·Status: COMPLETED ·Phase: PHASE1
-
Neonatal Hypoxic Ischemic Encephalopathy:Early Diagnosis and Management of Comorbidities
NCT03550612 ·Status: UNKNOWN
-
PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns
NCT03079167 ·Status: COMPLETED ·Phase: PHASE3
-
Erythropoietin in Premature Infants to Prevent Encephalopathy
NCT02550054 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Erythropoietin on Preterm Brain Injury
NCT02036073 ·Status: COMPLETED ·Phase: PHASE4
-
Does Erythropoietin Improve Outcome in Very Preterm Infants?
NCT00413946 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants
NCT01203514 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity
NCT00339001 ·Status: UNKNOWN
-
Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants
NCT00910234 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Erythropoietin Treatment in Extremely Low Birth Weight Infants
NCT00593801 ·Status: COMPLETED ·Phase: NA
-
''Efficacy of Propranolol in the Treatment of Infantile Hemangioma"
NCT04684667 ·Status: UNKNOWN ·Phase: PHASE2
-
Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis
NCT03919500 ·Status: COMPLETED ·Phase: PHASE2
-
Bedside Optical Retinal Assessment of Hypoxic Ischemic Encephalopathy in Infants
NCT03640494 ·Status: COMPLETED
-
Severity of Hypoxic Ischemic Encephalopathy and Neurological Pupil Index in Neonates
NCT07024771 ·Status: NOT_YET_RECRUITING
-
Magnetic Resonance Imaging and Spectroscopy Biomarkers of Neonatal Hypoxic Ischemic Encephalopathy
NCT01481207 ·Status: COMPLETED
-
Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)
NCT05395195 ·Status: RECRUITING ·Phase: PHASE3
-
Long Term Effects of Erythropoietin in Patients With Moderate to Severe Traumatic Brain Injury
NCT03061565 ·Status: COMPLETED
-
Metformin Treatment in Infants After Perinatal Brain Injury
NCT05590676 ·Status: TERMINATED ·Phase: PHASE1
-
Neonates with Hypoxic Ischemic Encephalopathy (HIE)
NCT06694545 ·Status: NOT_YET_RECRUITING